These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32925542)

  • 1. Low Pretreatment Viral Loads in Infants With HIV in an Era of High-maternal Antiretroviral Therapy Coverage.
    Patel F; Shiau S; Strehlau R; Shen Y; Burke M; Paximadis M; Shalekoff S; Schramm D; Technau KG; Sherman GG; Coovadia A; Tiemessen CT; Abrams EJ; Kuhn L
    Pediatr Infect Dis J; 2021 Jan; 40(1):55-59. PubMed ID: 32925542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with vertical transmission of HIV in the Western Cape, South Africa: a retrospective cohort analysis.
    Anderson K; Kalk E; Heekes A; Phelanyane F; Jacob N; Boulle A; Mehta U; Kassanjee R; Sridhar G; Ragone L; Vannappagari V; Davies MA
    J Int AIDS Soc; 2024 Mar; 27(3):e26235. PubMed ID: 38528395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
    HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.
    Kakkar F; Lamarre V; Ducruet T; Boucher M; Valois S; Soudeyns H; Lapointe N
    BMC Infect Dis; 2014 May; 14():236. PubMed ID: 24885498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015.
    Williams PL; Huo Y; Rutstein R; Hazra R; Rough K; Van Dyke RB; Chadwick EG
    AIDS Patient Care STDS; 2018 Feb; 32(2):48-57. PubMed ID: 30346801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
    Mandelbrot L; Tubiana R; Le Chenadec J; Dollfus C; Faye A; Pannier E; Matheron S; Khuong MA; Garrait V; Reliquet V; Devidas A; Berrebi A; Allisy C; Elleau C; Arvieux C; Rouzioux C; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Dec; 61(11):1715-25. PubMed ID: 26197844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The next generation: Pregnancy in adolescents and women living with perinatally acquired HIV in South Africa.
    Anderson K; Mutemaringa T; Technau KG; Johnson LF; Braithwaite K; Mokotoane E; Boulle A; Davies On Behalf Of IeDEA-Sa Pediatrics MA
    S Afr Med J; 2021 Mar; 111(3):260-264. PubMed ID: 33944749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
    Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
    J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 90-90-90 cascade analysis on reported CLHIV infected by mother-to-child transmission in Guangxi, China: a modeling study.
    Wang G; Lu C; Qin S; Wei W; Lai J; Jiang J; Liang B; Zhou O; Han J; Yang Y; Ye L; Liang H; Ning C
    Sci Rep; 2020 Mar; 10(1):5295. PubMed ID: 32210333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Viral Load Burden Among HIV-Infected Women Around the Time of Delivery: Findings From Four Tertiary Obstetric Units in Gauteng, South Africa.
    Moyo F; Haeri Mazanderani A; Murray T; Technau KG; Carmona S; Kufa T; Sherman GG
    J Acquir Immune Defic Syndr; 2020 Apr; 83(4):390-396. PubMed ID: 31914002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
    Venkatesh KK; Lurie MN; Triche EW; De Bruyn G; Harwell JI; McGarvey ST; Gray GE
    Trop Med Int Health; 2010 Nov; 15(11):1364-74. PubMed ID: 20955499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa.
    Manicklal S; van Niekerk AM; Kroon SM; Hutto C; Novak Z; Pati SK; Chowdhury N; Hsiao NY; Boppana SB
    Clin Infect Dis; 2014 May; 58(10):1467-72. PubMed ID: 24567248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence.
    Fernández-Luis S; Lain MG; Serna-Pascual M; Domínguez-Rodríguez S; Kuhn L; Liberty A; Barnabas S; Lopez-Varela E; Otwombe K; Danaviah S; Nastouli E; Palma P; Cotugno N; Spyer M; Giannuzzi V; Giaquinto C; Violari A; Cotton MF; Nhampossa T; Klein N; Ramsagar N; van Rensburg AJ; Behuhuma O; Vaz P; Maiga AI; Oletto A; Naniche D; Rossi P; Rojo P; Tagarro A;
    BMC Public Health; 2022 Jul; 22(1):1312. PubMed ID: 35804333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants.
    Kuhn L; Paximadis M; Da Costa Dias B; Shen Y; Mncube S; Strehlau R; Shiau S; Patel F; Burke M; Technau KG; Sherman G; Loubser S; Abrams EJ; Tiemessen CT
    Clin Infect Dis; 2022 Mar; 74(6):1047-1054. PubMed ID: 34185838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying the Dynamics of HIV Decline in Perinatally Infected Neonates on Antiretroviral Therapy.
    Morris SE; Dziobek-Garrett L; Strehlau R; Schröter J; Shiau S; Anelone AJN; Paximadis M; de Boer RJ; Abrams EJ; Tiemessen CT; Kuhn L; Yates AJ;
    J Acquir Immune Defic Syndr; 2020 Oct; 85(2):209-218. PubMed ID: 32576731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.